Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (371-380 of 496) with videos related to

Pageof 50
Sort By:
Rheumatology (Oxford, England)|July 16, 2021
Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohortLaura Pina Vegas, Emilie Sbidian, Daniel Wendling, et al.
Arthritis Research & Therapy|July 27, 2013
New autoantibodies in early rheumatoid arthritisCaroline Charpin, Fanny Arnoux, Marielle Martin, et al.
Joint Bone Spine|February 28, 2017
A bicentre retrospective study of features and outcomes of patients with reactive arthritisAudrey Courcoul, Anne Brinster, Evelyne Decullier, et al.
Joint Bone Spine|February 23, 2010
Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: observational study of 30 cases in everyday practiceEric Toussirot, Edouard Pertuiset, Christelle Sordet, et al.
Joint Bone Spine|November 12, 2022
Ophthalmic adverse events under tofacitinib and baricitinib: Case analysis of the European Pharmacovigilance DatabaseSophie Hecquet, Marie-Blanche Valnet Rabier, Marion Lepelley, et al.
RMD Open|March 18, 2022
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in FranceMaxime Dougados, Julien Lucas, Emilie Desfleurs, et al.
Joint Bone Spine|July 21, 2019
Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: Analysis of the ESPOIR cohortChloé Bernardy, Sophie Lejeune, Anaïs Courtier, et al.
Clinical and Experimental Rheumatology|January 9, 2019
Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohortValerie Nadon, Anna Moltó, Adrien Etcheto, et al.
RMD Open|September 6, 2020
Part of pain labelled neuropathic in rheumatic disease might be rather nociplasticFlorian Bailly, Alain Cantagrel, Philippe Bertin, et al.
Joint Bone Spine|June 26, 2025
Modifications of intestinal barrier dysfunction under tofacitinib administration in rat adjuvant arthritisSophie Hecquet, Perle Totoson, Hélène Martin, et al.
Pageof 50

Showing results (371-380 of 496) with videos related to

Sort By:
Pageof 50
Rheumatology (Oxford, England)|July 16, 2021
Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohortLaura Pina Vegas, Emilie Sbidian, Daniel Wendling, et al.
Arthritis Research & Therapy|July 27, 2013
New autoantibodies in early rheumatoid arthritisCaroline Charpin, Fanny Arnoux, Marielle Martin, et al.
Joint Bone Spine|February 28, 2017
A bicentre retrospective study of features and outcomes of patients with reactive arthritisAudrey Courcoul, Anne Brinster, Evelyne Decullier, et al.
Joint Bone Spine|February 23, 2010
Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: observational study of 30 cases in everyday practiceEric Toussirot, Edouard Pertuiset, Christelle Sordet, et al.
Joint Bone Spine|November 12, 2022
Ophthalmic adverse events under tofacitinib and baricitinib: Case analysis of the European Pharmacovigilance DatabaseSophie Hecquet, Marie-Blanche Valnet Rabier, Marion Lepelley, et al.
RMD Open|March 18, 2022
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in FranceMaxime Dougados, Julien Lucas, Emilie Desfleurs, et al.
Joint Bone Spine|July 21, 2019
Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: Analysis of the ESPOIR cohortChloé Bernardy, Sophie Lejeune, Anaïs Courtier, et al.
Clinical and Experimental Rheumatology|January 9, 2019
Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohortValerie Nadon, Anna Moltó, Adrien Etcheto, et al.
RMD Open|September 6, 2020
Part of pain labelled neuropathic in rheumatic disease might be rather nociplasticFlorian Bailly, Alain Cantagrel, Philippe Bertin, et al.
Joint Bone Spine|June 26, 2025
Modifications of intestinal barrier dysfunction under tofacitinib administration in rat adjuvant arthritisSophie Hecquet, Perle Totoson, Hélène Martin, et al.
Pageof 50